Medi Lifestyle has signed a non-binding term sheet to acquire a 60% stake in EM2AI, a Singapore-developed dental AI platform, from Q & M Dental Group. The acquisition, valued at approximately S$6.76m, will be completed through the issuance of 138 million new ordinary shares in Medi Lifestyle at S$0.049 each. This strategic move aims to integrate technology-enabled healthcare into Medi Lifestyle’s offerings, leveraging EM2AI’s live clinical deployment and potential for commercialisation across dental networks.
The proposed transaction includes profit targets of S$1m, S$1.5m, and S$2.5m for the financial years 2027, 2028, and 2029, respectively. Medi Lifestyle plans to conduct a fundraising exercise through private placement to support its business expansion and strategic growth initiatives.
According to Tan Lee Seng, Executive Director and CEO of Medi Lifestyle, “EM2AI gives Medi Lifestyle a clear entry point into technology-enabled healthcare. Its technology has progressed from research into a live dental network, where AI supports X-ray assessment and clinical workflows. We see an opportunity to combine EM2AI’s dental and engineering capabilities with Medi Lifestyle’s capital base, operating support, and regional ambitions.”
This acquisition marks a significant step for Medi Lifestyle as it seeks to enhance its technological capabilities and expand its footprint in the healthcare sector. The integration of EM2AI’s platform is expected to bolster Medi Lifestyle’s position in the market, offering innovative solutions to dental networks.
